Allis-Chalmers Energy Sells Capillary Tubing Units For $16.25 Mln …RTT News, NY - 19 hours ago6/29/2007 12:18:31 PM Friday, Biogen Idec (BIIB) reported the departure of the company's Executive Vice President of Finance & Chief Financial Officer Peter …
Read full story
Biogen Idec Announces Management ChangeNDTV.com, India - 44 minutes ago“Peter is a world-class financial executive who helped Biogen Idec grow our core therapeutic areas, execute several significant deals, and expand our global …Biogen Idec finance chief to leave firm in August Boston GlobeBiogen CFO Kellogg resigns to become CFO at Merck ReutersBiogen Idec's Chief Financial Officer Peter Kellogg Quits; To Join … RTT NewsMarketWatch - CNNMoney.comall 31 news articles
Read full story
Biogen Idec's Chief Financial Officer Peter Kellogg Quits; To Join …RTT News, NY - 6 hours agoCommenting on Kellogg's exit, James Mullen, President and Chief Executive Officer, Biogen Idec, said, "I want to thank Peter for his seven years of …Biogen CFO Kellogg resigns to become CFO at Merck ReutersBiogen CFO leaves for Merck MarketWatchBiogen CFO moves to Merck CNNMoney.comForbes - TheStreet.comall 21 news articles
Read full story
Aegon To Merge PTE Ergo Hestia With BRE Bank's PTE Skarbiec-EmeryturaRTT News, NY - 6 hours agoKellogg joins Merck from Biogen Idec Inc., where he held the position of executive vice president and chief financial officer. …AEGON and BRE Bank to Merge Polish Pension Funds CNNMoney.comAegon says to merge Polish pension funds with BRE Bank ForbesAegon says to merge Polish pension funds with BRE Bank CNNMoney.comCNNMoney.comall 15 news articles
Read full story
Keryx Biopharma Presents Phase I And Phase II Data On KRX-0401RTT News, NY - 6 hours agoCommenting on Kellogg's exit, James Mullen, President and Chief Executive Officer, Biogen Idec, said, "I want to thank Peter for his seven years of …Niko Resources Q4 Net Loss Narrows, FFO Per Share Rises, Revenues … RTT NewsKeryx Biopharma Reveals Phase I And Phase II Data On KRX-0401 … RTT NewsA. Schulman Reorganizes North American Operations Into Three Major … RTT NewsRTT News - RTT Newsall 7 news articles
Read full story
Ahead of the Bell: Biogen IdecForbes, NY - Jun 26, 2007AP 06.26.07, 8:27 AM ET A Lehman Brothers analyst downgraded shares of Biogen Idec Inc. Tuesday, saying flat sales of multiple sclerosis treatment Avonex …
Read full story
UCB and Biogen Idec start Phase II study for oral MS drugForbes, NY - Jun 25, 2007LONDON (Thomson Financial) - UCB SA and US-based Biogen Idec Inc said they began Phase II study of CDP323 — an oral drug under development for multiple …
Read full story
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II …Canada NewsWire (press release), Canada - Jun 25, 2007About Biogen Idec Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global …
Read full story
UCB, Biogen Idec Initiate Phase II Study Of CDP323 For Multiple …RTT News, NY - Jun 26, 2007UCB and Biogen Idec said that the data from these early studies support the further development of CDP323. The data from these studies were reported at the …
Read full story
Biogen Idec to Present at the Jefferies Healthcare ConferenceGenetic Engineering News (press release), NY - Jun 25, 2007Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the Jefferies Healthcare Conference will be webcast live via the internet, …
Read full story
ViroPharma's Hepatitis C Drug Fast Tracked and Genzyme Corporation …Financial News USA (press release), CA - 13 hours agoBiogen Idec Inc. (NASDAQ: BIIB) recently announced the preliminary results of its modified "Dutch Auction" tender offer which expired at 12:00 midnight ET …
Read full story
Biogen Idec "neutral," estimates raisednewratings.com - 13 hours agoNEW YORK, June 28 (newratings.com) - Analysts at Robert W Baird reiterate their "neutral" rating on Biogen Idec Inc (BIIB.NAS), while raising their …Ahead of the Bell: Biogen Idec Forbesall 3 news articles
Read full story
Biogen Idec To Accept For Payment An Aggregate Of 56.4 Mln Shares …RTT News, NY - 23 hours ago6/27/2007 8:57:08 AM Biogen Idec Inc. (BIIB) on Wednesday revealed the preliminary results of its modified Dutch Auction tender offer which expired on June …
Read full story
S&P Volatility: Drug MakersHouston Chronicle, United States - 19 hours agoWithin the group, the highest-volatility stock is Biogen Idec, with a beta value of 1.25. The least-volatile stock is Johnson & Johnson, with a beta value …
Read full story
Biogen Idec Announces Preliminary Results of Its Modified “Dutch …Business Wire (press release), CA - 23 hours agoBiogen Idec expects to accept for payment an aggregate of 56428198 shares of its common stock at a purchase price of $53 per share, for an aggregate share …Biogen Idec (BIIB) Expects To Purchase 56.4M Shares at $53 in … StreetInsider.com (subscription)Biogen Tender Offer Nets 56.4M Shares ForbesBiogen to buy 56.4M shares of own shares MSN MoneyHouston Chronicleall 10 news articles
Read full story
Commercial Insight: Multiple Sclerosis Continued growth makes the …Pharmaceutical Business Review - 11 hours agoTo ensure continued revenue and to minimize franchise risk companies can follow Biogen Idec's strategy to market two or more products and show commitment to …
Read full story
Ahead of the Bell: Biogen IdecHouston Chronicle, United States - 11 hours ago2007 AP NEW YORK — A Lehman Brothers analyst downgraded shares of Biogen Idec Inc. Tuesday, saying flat sales of multiple sclerosis treatment Avonex are not …Ahead of the Bell: Biogen Idec Forbesall 6 news articles
Read full story
Biogen Idec Inc. (BIIB) Holds Near Recent PeakSchaeffers Research, OH - 9 hours agoOne of the more interesting stocks from today's upgrade and downgrade list is Biogen Idec Inc. (BIIB). Once upon a time, Biogen was a biotech star - a …
Read full story
SOURCE: Wall Street News AlertMarketwire (press release), Canada - 11 hours agoBiogen Idec Inc. ( NASDAQ : BIIB) up 0.3% on 13.3 million shares traded. Biogen Idec creates new standards of care in oncology, neurology and immunology. …
Read full story
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II …NDTV.com, India - 4 hours agoBiogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the …UCB en Oral VLA-4 Antogonist van Biogen Idec starten fase II … Netherlands Corporate News (persbericht)UCB, Biogen Idec Initiate Phase II Study Of CDP323 For Multiple … RTT NewsUCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II … Canada NewsWire (press release)all 11 news articles
Read full story